Addressing intellectual property challenges, providing greater incentives for industry, and continuing to promote education were areas named by Sandoz as those needing closer monitoring and improvement to foster greater competition for biosimilars during off-patent industry association Medicines for Europe’s 2022 annual conference.
Addressing delegates to the conference in Sitges, Barcelona, last week, Sandoz’s general counsel and global legal head, Ingrid Sollerer, observed...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?